Article 1
Open βAnnex IV to Regulation (EC) No 1210/2003 is amended as set out in the Annex to this Regulation.
Source
Commission Implementing Regulation (EU) 2021/53 of 22 January 2021 amending Council Regulation (EC) No 1210/2003 concerning certain specific restrictions on economic and financial relations with Iraq
Commission Implementing Regulation (EU) 2021/53 of 22 January 2021 amending Council Regulation (EC) No 1210/2003 concerning certain specific restrictions on economic and financial relations with Iraq
Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β
Article 2
Open βThis Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union .
Supplementary provisions
ANNEXSupplementary provisions
Open βANNEX In Annex IV to Regulation (EC) No 1210/2003, the following entries are deleted: β31. NAME: Zuhair Talib Abd-al-Sattar Al-Naqib. DATE OF BIRTH/PLACE OF BIRTH: Circa 1948. NATIONALITY: Iraq. UNSC RESOLUTION 1483 BASIS: Director, Military Intelligence.β β33. NAME: Amir Rashid Muhammad Al-Ubaidi. DATE OF BIRTH/PLACE OF BIRTH: 1939, Baghdad. NATIONALITY: Iraq. UNSC RESOLUTION 1483 BASIS: Minister of Oil, 1996 to 2003; Head, Organisation of Military Industrialisation, early 1990s.β
Other acts of the same type
Commission Implementing Regulation (EU) 2017/703 of 5 April 2017 entering a name in the register of protected designations of origin and protected geographical indications (Vitelloni Piemontesi della coscia (PGI))Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/637 of 4 April 2017 amending for the 265th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaeda organisationsCommission Implementing Regulation (EU) 2017/702 of 4 April 2017 entering a name in the register of protected designations of origin and protected geographical indications (Marche (PGI))Commission Regulation (EU) 2017/627 of 3 April 2017 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for fenpyroximate, triadimenol and triadimefon in or on certain products (Text with EEA relevance. )Council Implementing Regulation (EU) 2017/628 of 3 April 2017 implementing Article 15(3) of Regulation (EU) No 1352/2014 concerning restrictive measures in view of the situation in YemenCommission Implementing Regulation (EU) 2017/630 of 3 April 2017 amending for the 264th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaeda organisationsCommission Regulation (EU) 2017/626 of 31 March 2017 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, cyantraniliprole, cypermethrin, cyprodinil, difenoconazole, ethephon, fluopyram, flutriafol, fluxapyroxad, imazapic, imazapyr, lambda-cyhalothrin, mesotrione, profenofos, propiconazole, pyrimethanil, spirotetramat, tebuconazole, triazophos and trifloxystrobin in or on certain products (Text with EEA relevance. )Commission Regulation (EU) 2017/623 of 30 March 2017 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acequinocyl, amitraz, coumaphos, diflufenican, flumequine, metribuzin, permethrin, pyraclostrobin and streptomycin in or on certain products (Text with EEA relevance. )Commission Regulation (EU) 2017/624 of 30 March 2017 amending Annexes II and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bifenazate, daminozide and tolylfluanid in or on certain products (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/635 of 30 March 2017 concerning the classification of certain goods in the Combined Nomenclature
Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.
What to look at next
Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislationEU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and yearEuropean Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview